| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9880310 | Journal of the Neurological Sciences | 2005 | 5 Pages |
Abstract
Multiple sclerosis is generally considered a disease of the white matter. However, this is only one pathological aspect of the disease as demyelination is prominent in the grey matter of deep cerebral nuclei and the cerebral cortex. In this review, we discuss the possibility that disease involvement of grey matter structures may significantly contribute to clinical disability in multiple sclerosis patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Alexandra Kutzelnigg, Hans Lassmann,